MXPA02006049A - Amonio cuaternario y su uso como agente antitusivo. - Google Patents

Amonio cuaternario y su uso como agente antitusivo.

Info

Publication number
MXPA02006049A
MXPA02006049A MXPA02006049A MXPA02006049A MXPA02006049A MX PA02006049 A MXPA02006049 A MX PA02006049A MX PA02006049 A MXPA02006049 A MX PA02006049A MX PA02006049 A MXPA02006049 A MX PA02006049A MX PA02006049 A MXPA02006049 A MX PA02006049A
Authority
MX
Mexico
Prior art keywords
quaternary ammonium
antitussive agent
compounds
yje
andor
Prior art date
Application number
MXPA02006049A
Other languages
English (en)
Inventor
Lewis Siu Leung Choi
Original Assignee
Ucb Farchim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim Sa filed Critical Ucb Farchim Sa
Publication of MXPA02006049A publication Critical patent/MXPA02006049A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

En un aspecto, la presente invencion se refiere al uso de ciertos compuestos de amonio cuatemario como ingrediente activo en la fabricacion de un medicamento para utilizarse en el tratamiento y/o prevencion de tos en animales de sangre caliente, incluyendo seres humanos, compuestos tales como los de la formula (I) en donde J se selecciona independientemente del grupo que esta representado por una de las formulas (II), (III) y (IV). (ver formula).
MXPA02006049A 1999-12-15 2000-12-15 Amonio cuaternario y su uso como agente antitusivo. MXPA02006049A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2292343 1999-12-15
PCT/CA2000/001508 WO2001044167A1 (en) 1999-12-15 2000-12-15 Quaternary ammonium compounds and their use as anti-tussive agents

Publications (1)

Publication Number Publication Date
MXPA02006049A true MXPA02006049A (es) 2004-08-23

Family

ID=4164883

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02006049A MXPA02006049A (es) 1999-12-15 2000-12-15 Amonio cuaternario y su uso como agente antitusivo.

Country Status (22)

Country Link
US (2) US20030181489A1 (es)
EP (1) EP1254104B1 (es)
JP (1) JP2003517034A (es)
KR (1) KR20020092352A (es)
CN (1) CN1423630A (es)
AT (1) ATE293097T1 (es)
AU (1) AU2334701A (es)
BG (1) BG106815A (es)
BR (1) BR0016427A (es)
CZ (1) CZ20022097A3 (es)
DE (1) DE60019465D1 (es)
EE (1) EE200200315A (es)
HU (1) HUP0203918A3 (es)
IL (1) IL150181A0 (es)
IS (1) IS6416A (es)
MX (1) MXPA02006049A (es)
NO (1) NO20022868L (es)
NZ (1) NZ519747A (es)
PL (1) PL355944A1 (es)
RU (1) RU2002116212A (es)
WO (1) WO2001044167A1 (es)
ZA (1) ZA200205567B (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703324A (en) * 1950-08-30 1955-03-01 Bristol Lab Inc Basic ethers of aralkyl phenols and salts thereof
US2642434A (en) * 1951-09-05 1953-06-16 Sterling Drug Inc Quaternary ammonium salts of lower alkyl 4-substituted-2-(tertiaryaminoalkoxy) benzoates and their preparation
US2913459A (en) * 1954-12-09 1959-11-17 Eprova Ltd New quaternary ammonium compounds and process for the production thereof
GB919126A (en) * 1958-07-01 1963-02-20 Wellcome Found Quaternary ammonium compounds and their preparation
GB935613A (en) * 1960-02-04 1963-08-28 Wellcome Found Quaternary ammonium compounds and their preparation
US3840666A (en) * 1972-07-05 1974-10-08 Univ Michigan Anti-arrhythmic quaternary salt compositions and methods of use
US4048335A (en) * 1974-06-17 1977-09-13 The Regents Of The University Of Michigan Method of inhibiting myocardial ischemia in mammals using quaternary salts
DE2940765A1 (de) * 1979-10-08 1981-04-23 Basf Ag, 6700 Ludwigshafen Substituierte alkylammoniumsalze, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer
AU761663B2 (en) * 1998-06-09 2003-06-05 Nortran Pharmaceuticals Inc. Quarternary ammonium compounds as anti-tussive agents

Also Published As

Publication number Publication date
US20050197383A1 (en) 2005-09-08
RU2002116212A (ru) 2004-02-10
BR0016427A (pt) 2002-10-29
IS6416A (is) 2002-06-12
AU2334701A (en) 2001-06-25
KR20020092352A (ko) 2002-12-11
ATE293097T1 (de) 2005-04-15
BG106815A (en) 2003-04-30
DE60019465D1 (de) 2005-05-19
NO20022868D0 (no) 2002-06-14
WO2001044167A1 (en) 2001-06-21
NZ519747A (en) 2003-08-29
CN1423630A (zh) 2003-06-11
EP1254104A1 (en) 2002-11-06
ZA200205567B (en) 2003-10-13
US20030181489A1 (en) 2003-09-25
CZ20022097A3 (cs) 2002-11-13
NO20022868L (no) 2002-08-14
PL355944A1 (en) 2004-05-31
WO2001044167A8 (en) 2001-12-06
JP2003517034A (ja) 2003-05-20
HUP0203918A2 (hu) 2003-03-28
IL150181A0 (en) 2002-12-01
EE200200315A (et) 2003-08-15
HUP0203918A3 (en) 2005-06-28
EP1254104B1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
WO2001085212A3 (en) Drug delivery systems for photodynamic therapy
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
DE60112609D1 (en) Pyrazolopyridine
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
YU6303A (sh) Nova heterociklična jedinjenja, njihovo dobijanje i njihova upotreba kao medikamenata, a naročito kao anti-bakterijskih agenasa
HK1053115A1 (en) Quinazoline derivatives for the treatment of tumours.
YU29601A (sh) Novi estri izvedeni iz supstituisanih fenil-cikloheksil jedinjenja
WO2005056524A3 (en) Therapeutic agents useful for treating pain
WO2005030753A3 (en) Therapeutic agents useful for treating pain
WO1999012532A3 (en) Piperidine derivatives against malaria
MXPA02006051A (es) Compuestos de amonio cuaternario ciclico.
BR9405139A (pt) Derivados do triazol, inseticida e acaricida e processos para produção dos mesmos
MXPA02006050A (es) Sales cuaternarias de aminas ciclicas o aciclicas n-sustituidas como productos farmaceuticos.
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
HRP20070441T3 (en) Pharmaceutical combination for the treatment of spasticity and/or pain
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
WO2000016757A8 (de) Verwendung von phosphororganischen verbindungen zur herstellung von arzneimitteln zur therapeutischen und prophylaktischen behandlung von infektionen oder als fungizid, bakterizid oder herbizid bei pflanzen
MXPA02006049A (es) Amonio cuaternario y su uso como agente antitusivo.
WO2002055022A3 (en) Active metabolite of antifungal compound
GB0012795D0 (en) Organic compounds
CA2133186A1 (en) 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
YU30602A (sh) Primena 2-amino-3,4-dihidro-hinazolina za proizvodnju leka za lečenje ili profilaksu bolesti koje su prouzrokovane ishemičnim stanjima
CA2409845A1 (en) Active substance combination containing a compound with an opioid effect and at least one further compound of formula i